Vascular Health and Risk Management

Erratum

Vascular Health and Risk Management 2006, 2:515-515

Published Date: 15 December 2006

Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level

Daria Roccatagliata, Fausto Avanzini, Lara Monesi, Vittorio Caimi, Davide Lauri, Paolo Longoni, Roberto Marchioli, Massimo Tombesi, Gianni Tognoni, Maria Carla Roncaglioni, on behalf of the Collaborative Group Risk and Prevention Study

Vascular Health and Risk Management 2006, 2:507-514

Published Date: 15 December 2006

Hypothyroidism in coronary heart disease and its relation to selected risk factors

Otto Mayer Jr, Jaroslav Šimon, Jan Filipovský, Markéta Plášková, Richard Pikner

Vascular Health and Risk Management 2006, 2:499-506

Published Date: 15 December 2006

Assessment of cognitive function in patients with essential hypertension treated with lercanidipine

J Tisaire-Sánchez, J Roma, Ignacio Camacho-Azcargorta, J Bueno-Gómez, J Mora-Maciá, Angel Navarro

Vascular Health and Risk Management 2006, 2:491-498

Published Date: 15 December 2006

Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects

Liliana Legedz, Giampiero Bricca, Pierre Lantelme, Marie-Odile Rial, Pierre Champomier, Madeleine Vincent, Hugues Milon

Vascular Health and Risk Management 2006, 2:485-490

Published Date: 15 December 2006

Outcomes of coronary artery bypass graft surgery

Anna Louise Hawkes, Madeleine Nowak, Benjamin Bidstrup, Richard Speare

Vascular Health and Risk Management 2006, 2:477-484

Published Date: 15 December 2006

Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment

Leila Fernandes Araujo, Alexandre de Matos Soeiro, Juliano Lara Fernandes, Antônio Eduardo Pesaro, Carlos V Serrano Jr

Vascular Health and Risk Management 2006, 2:465-475

Published Date: 15 December 2006

The impact of health literacy on cardiovascular disease

Richard S Safeer, Catherine E Cooke, Jann Keenan

Vascular Health and Risk Management 2006, 2:457-464

Published Date: 15 December 2006

Sexual function in hypertensive patients receiving treatment

Thorsten Reffelmann, Robert A Kloner

Vascular Health and Risk Management 2006, 2:447-455

Published Date: 15 December 2006

Who should receive a statin drug to lower cardiovascular risk? Does the drug and the dose of the drug matter?

JV (Ian) Nixon

Vascular Health and Risk Management 2006, 2:441-446

Published Date: 15 December 2006

Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients

Heng Joo Ng, Lai Heng Lee

Vascular Health and Risk Management 2006, 2:433-440

Published Date: 15 December 2006

Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure

Melvin R Echols, Clyde W Yancy

Vascular Health and Risk Management 2006, 2:423-431

Published Date: 15 December 2006

Sildenafil in the treatment of pulmonary hypertension

Christopher F Barnett, Roberto F Machado

Vascular Health and Risk Management 2006, 2:411-422

Published Date: 15 December 2006

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension

Mark Greathouse

Vascular Health and Risk Management 2006, 2:401-409

Published Date: 15 December 2006

A review of levosimendan in the treatment of heart failure

Hulya Akhan Kasikcioglu, Nese Cam

Vascular Health and Risk Management 2006, 2:389-400

Published Date: 15 December 2006

Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)

Huyen Tran, Shamir R Mehta, John W Eikelboom

Vascular Health and Risk Management 2006, 2:379-387

Published Date: 15 December 2006

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction

Alexander GG Turpie

Vascular Health and Risk Management 2006, 2:371-378

Published Date: 15 December 2006

Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery

David Bergqvist

Vascular Health and Risk Management 2006, 2:365-370

Published Date: 15 December 2006

Bivalirudin in percutaneous coronary intervention

Sam J Lehman, Derek P Chew

Vascular Health and Risk Management 2006, 2:357-363

Published Date: 15 December 2006

Management of cancer-associated venous thrombosis

Ozlem Er, Leo Zacharski

Vascular Health and Risk Management 2006, 2:351-356

Published Date: 15 December 2006

Olmesartan medoxomil: current status of its use in monotherapy

Hans R Brunner

Vascular Health and Risk Management 2006, 2:327-340

Published Date: 15 December 2006

Society News: ISVH – A multi-disciplinary society ||FREE PAPER||

Roland Asmar

Vascular Health and Risk Management 2006, 2:325-326

Published Date: 15 December 2006